Identifying Infliximab- (IFX-) Responsive Blood Signatures for the Treatment of Rheumatoid Arthritis

Table 2

Classification rules yielded by RIPPER.

Index	Condition	Result	Support^#	Accuracy^$
1		IFX-sensitive patient	7.86%	90.91%
2		IFX-sensitive patient	7.14%	90.00%
3	Others	IFX-resistant patient	85.00%	80.67%

^#Support is defined as the proportion of samples satisfying the rule to all samples. ^$Accuracy is defined as the proportion of correctly predicted samples to the samples satisfying the rule.